To overcome this issue, Neal et al. proposed a co-cultured system of cancer organoids and endogenous tumor infiltrating lymphocytes to test the drug response of anti-PD-1 or anti-PD-L1 immune check point inhibitors [33]. Here, CD274 is linked to neoplasm.